Residual β-Cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents.
about
Hemoglobin A1c (HbA1c) changes over time among adolescent and young adult participants in the T1D exchange clinic registry.Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.Low levels of C-peptide have clinical significance for established Type 1 diabetes.Incidence of severe hypoglycemia in children with type 1 diabetes in the Nordic countries in the period 2008-2012: association with hemoglobin A 1c and treatment modality.Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.Factors Associated with C-peptide Levels after Diagnosis in Children with Type 1 Diabetes Mellitus.Meta-genome-wide association studies identify a locus on chromosome 1 and multiple variants in the MHC region for serum C-peptide in type 1 diabetes.Insulin-Like Growth Factor-1 at Diagnosis and during Subsequent Years in Adolescents with Type 1 Diabetes.Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis.Integration of Routine Parameters of Glycemic Variability in a Simple Screening Method for Partial Remission in Children with Type 1 Diabetes.
P2860
Q30279053-B7BC49F2-DFBB-48B9-AFE9-8682C3F7853BQ31099230-D8C839AD-22CC-4DC0-BA0C-C1323FBD7845Q33620874-5A8C0C63-E468-4380-A9DA-A8878BB5DF48Q34484912-2BA76869-D2A2-4B5C-A8B5-73B862082C09Q38650412-F7034A9B-2E31-49EF-BE56-D62F4EF51E87Q40088521-8503E1C8-3BE1-488E-BDC3-A2E57D368312Q42261993-0EF6BCE3-0710-438C-9AD3-2E101E5DD5DBQ50060749-EB6193ED-246F-4C50-80F4-1ADB4F0617E3Q55356914-16D7567D-49D9-4074-99A0-F18C1A91DA86Q55394140-5E635572-EF51-4B37-9C9C-7115AF33855AQ55451980-4FF65ED1-F3DC-435C-A21E-F4D0F856D436
P2860
Residual β-Cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Residual β-Cell function 3-6 y ...... a in children and adolescents.
@en
Residual β-Cell function 3-6 y ...... a in children and adolescents.
@nl
type
label
Residual β-Cell function 3-6 y ...... a in children and adolescents.
@en
Residual β-Cell function 3-6 y ...... a in children and adolescents.
@nl
prefLabel
Residual β-Cell function 3-6 y ...... a in children and adolescents.
@en
Residual β-Cell function 3-6 y ...... a in children and adolescents.
@nl
P2093
P2860
P50
P356
P1433
P1476
Residual β-Cell function 3-6 y ...... a in children and adolescents.
@en
P2093
Danish Society for Diabetes in Childhood and Adolescence
Jesper S Sørensen
Kurt Kristensen
N Thomas Hertel
Niels H Birkebaek
Per Kjaersgaard
P2860
P304
P356
10.2337/DC13-0418
P407
P577
2013-08-29T00:00:00Z